Overview
Introducing the EndoClear™ rat recombinant a-Synuclein protein, a critical tool for researchers studying neurological conditions, particularly Parkinson’s disease. This protein, predominantly expressed in the brain’s cerebellum, thalamus, neocortex, hippocampus, and striatum regions, plays a significant role in understanding the pathophysiology of this neurodegenerative disorder. Its structure includes a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with notable sequence divergence, making it a valuable asset for your research.
Key Features
- High purity recombinant a-Synuclein protein from rat sources
- Integral for studying Lewy bodies in Parkinson’s disease
- Expressed in key brain regions crucial for neurological research
- Supports various applications, including assay kits and protein labeling
- Available for purchase from our extensive catalog recombinant collection
Specifications
| Property | Details |
|---|---|
| Source | Rat |
| Protein Type | Recombinant |
| Application | Research, diagnostic |
| Storage | Store at -20°C |
FAQ
What is a-Synuclein protein?
a-Synuclein is a protein that accumulates in the brains of individuals with Parkinson’s disease, forming Lewy bodies that are characteristic of the condition.
How is the EndoClear™ rat recombinant a-Synuclein protein used in research?
This recombinant protein is vital for studying the pathology of Parkinson’s disease and evaluating potential therapeutic targets and biomarkers.
Can this protein be used with assay kits?
Yes, the EndoClear™ rat recombinant a-Synuclein protein is compatible with various assay kits and labeling applications, enhancing your research capabilities.
Don’t miss out on acquiring the EndoClear™ rat recombinant a-Synuclein protein. Whether you are conducting in-depth research or developing new assays, this protein is an essential component for advancing your studies in neurological health. Shop now to bring increased clarity to your research!




Reviews
There are no reviews yet.